⭐️B.Grimm Pharma Collaborates with Inter Mohosot to Expand Distribution of Medicines in Cambodia.🎉 We are pleased to announce our Sole Distribution Agreement with Inter Mohosot Co., Ltd., aimed at enhancing access to quality medications in Cambodia. Starting January 2025, this partnership will cover various therapeutic areas, including the Cardiovascular, Central Nervous, and Musculoskeletal systems, providing over 16 essential medications for conditions such as depression, epilepsy, hypertension, and diabetes.💊🩺🏥 Mr. Kittisak Dumrongtananurak, Head of B.Grimm Pharma, emphasized, “With the growing demand for medications in Cambodia, we are ready to meet the needs for quality pharmaceuticals. Partnering with Inter Mohosot, a trusted company with deep insights into the Cambodian market, will not only support our expansion but also enhance access to quality medications for a broader population beyond Thailand.” Mr. Koy Borey, CEO of Inter Mohosot Co. Ltd., shared his enthusiasm: “We are excited to partner with B.Grimm Pharma to promote access to quality medications in Cambodia. By leveraging our expertise and network, we aim to complement B.Grimm Pharma’s commitment to product quality and improve healthcare opportunities for Cambodian citizens.” Together, we are dedicated to ensuring widespread availability of quality treatments, contributing to the growth of the Cambodian healthcare market. This partnership is more than just a business opportunity; it reflects our shared commitment to improving the quality of life for people in Cambodia. We look forward to making a positive impact on the healthcare landscape! #BGrimmPharma
-
5